NCEPOD Transition study - young person and parent carer online survey
NCEPOD are undertaking a study to look at the process of transition from child to adult health services. As part of this study, they are collecting the views of young people and parent carers on the transition process via an online survey.
The link to share with any relevant patient/ parent groups is https://ncepod.qualtrics.com/jfe/form/SV_5t0grqVhJMWrzsW
The survey will be open until May 2022
ABCD publishes the results of the Integrated survey about diabetes services
Today, 17th December 2021, ABCD publishes the results of the Integrated survey about diabetes services.
https://bjd-abcd.com/index.php/bjd/article/view/781
Please find the link to the raw data of this survey below.
Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is based on AstraZeneca’s decision to remove the Type 1 diabetes indication for dapagliflozin 5mg.
ABCD are disappointed that the use of dapaglifozin has been withdrawn for people with type 1 diabetes.
This is not due to any safety concern for dapagliflozin in any indication, including people with type 1 diabetes.
Investigating the Impact of a Dedicated Diabetes-Stroke Multi-Disciplinary Team (D/S-MDT) on Patient Outcomes, Referrals and Staff Satisfaction
Raunak Chugani Chandiramani, Laura Storey, Mina Mansor, Neil Hill
Imperial College London
The rare occurrence of Type B insulin resistance syndrome (TBRIS) in a T1DM patient. Could an insulin pump be the solution?
Melvin Lee Yoong Zher, Andrew Pettit
Department of Diabetes and Endocrinology, Division of Internal Medicine, Airedale General Hospital
Flash blood glucose monitoring (Freestyle Libre) improves glycemic control and reduces hospital admissions for diabetic ketoacidosis and severe hypoglycemia in community dwelling people with type 1 diabetes receiving limited specialist care
Yin WL; Wong E; Moses J; Minton D; Hussain R; Obuobie K
oyal Gwent Hospital, Newport, Ysbyty Ystrad Fawr, General Practice; Aneurin Bevan University Health Board
Screening for gestational diabetes: Comparing NICE criteria vs. RCOG criteria recommended during the Covid pandemic – role of HbA1c in GDM screening
Varughese MS, Nayak AU
University Hospital of North Midlands NHS Trust, Stoke on Trent
Mental health case-management significantly reduces hospital admissions and bed days in adults with Type 1 Diabetes Mellitus
Subramaniam Y1, Huda M1, Garrett C1,2
1 Department of Diabetes and Metabolism, Royal London Hospital, Barts Health NHS Trust
2 Department of Psychological Medicine, Royal London Hospital, East London Foundation Trust
Outcomes in patients with lipodystrophy receiving treatment with metreleptin via the National Severe Insulin Resistance Service at Addenbrookes Hospital, Cambridge
Stears AJ; Flanagan CL, Gaff L; Gorman S; Jenkins-Liu C: Savage DB; Williams R; Withers E; O’Rahilly S
Wolfson Centre for Diabetes and Endocrinology, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge
